Azotemia and Acute Kidney Injury: Diagnostic Criteria and Clinical Implications

Definitions and Diagnostic Criteria

Azotemia is defined as the accumulation of nitrogenous waste products in the blood, which can occur in various clinical contexts and does not necessarily indicate kidney damage, according to the American College of Radiology 1.
Acute Kidney Injury (AKI) is defined by specific criteria: an increase in serum creatinine by ≥0.3 mg/dL within 48 hours, or an increase to ≥1.5 times baseline within 7 days, or urine volume <0.5 mL/kg/h for 6 hours, as stated by the Kidney International and American College of Radiology 1, 2.
Prerenal azotemia is a condition where blood urea nitrogen is elevated due to decreased renal perfusion without intrinsic kidney damage, which may or may not progress to AKI, according to Clinical Gastroenterology and Hepatology 3.

AKI is part of a spectrum of kidney disorders that includes Acute Kidney Disease (AKD) and Chronic Kidney Disease (CKD), with specific time-based definitions, as defined by Clinical Nutrition and Kidney International AKI: Kidney dysfunction occurring over less than 7 days, as stated by Kidney International 2 and Clinical Nutrition 4
- AKD: Kidney dysfunction present for 7 days to 3 months, according to Clinical Nutrition and Kidney International 4, 5
- CKD: Kidney dysfunction present for more than 3 months, as defined by Clinical Nutrition and Kidney International 4, 5

Future diagnostic approaches may incorporate kidney damage biomarkers, biopsy findings, and imaging to better characterize AKI, moving beyond the current reliance on creatinine and urine output, as suggested by Kidney International 2.
The concept of Acute Kidney Disease (AKD) has been proposed to bridge the gap between AKI and CKD, encompassing conditions that don't meet strict criteria for either, according to Nature Reviews Nephrology and Kidney International 5, 6.